Journal Article
M. Okuda, Fujita, Y., Hijikuro, I., Wada, M., Uemura, T., Kobayashi, Y., Waku, T., Tanaka, N., Nishimoto, T., Izumi, Y., Kume, T., Akaike, A., Takahashi, T., and Sugimoto, H.,
“PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8.”,
J Alzheimers Dis, vol. 59, no. 1, pp. 313-328, 2017.
D. Chiasserini, Biscetti, L., Farotti, L., Eusebi, P., Salvadori, N., Lisetti, V., Baschieri, F., Chipi, E., Frattini, G., Stoops, E., Vanderstichele, H., Calabresi, P., and Parnetti, L.,
“Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.”,
J Alzheimers Dis, vol. 54, no. 1, pp. 55-67, 2016.
D. Chiasserini, Biscetti, L., Farotti, L., Eusebi, P., Salvadori, N., Lisetti, V., Baschieri, F., Chipi, E., Frattini, G., Stoops, E., Vanderstichele, H., Calabresi, P., and Parnetti, L.,
“Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.”,
J Alzheimers Dis, vol. 54, no. 1, pp. 55-67, 2016.
J. A. Luchsinger, Teresi, J. A., Valdez, L., Rosario, D., de Miguel, M., Taylor, D., Singer, J., Chang, N., Fuller, W. S., Boquín, C., Silver, S., Eimicke, J. P., Kong, J., Goldberg, T. E., and Devanand, D. P.,
“Performance of a smell identification test versus the Mini-Mental Status Exam for the detection of dementia and cognitive impairment among persons with cognitive concerns in primary care.”,
J Alzheimers Dis, p. 13872877251345083, 2025.
P. Suppa, Hampel, H., Kepp, T., Lange, C., Spies, L., Fiebach, J. B., Dubois, B., and Buchert, R.,
“Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 51, no. 3, pp. 867-73, 2016.
S. A. Farr, Sandoval, K. E., Niehoff, M. L., Witt, K. A., Kumar, V. B., and Morley, J. E.,
“Peripheral Administration of GSK-3β Antisense Oligonucleotide Improves Learning and Memory in SAMP8 and Tg2576 Mouse Models of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 54, no. 4, pp. 1339-1348, 2016.
R. Milne, Bunnik, E., Diaz, A., Richard, E., Badger, S., Gove, D., Georges, J., Fauria, K., Molinuevo, J. - L., Wells, K., Ritchie, C., and Brayne, C.,
“Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.”,
J Alzheimers Dis, vol. 62, no. 2, pp. 487-498, 2018.
I. Koychev, Gunn, R. N., Firouzian, A., Lawson, J., Zamboni, G., Ridha, B., Sahakian, B. J., Rowe, J. B., Thomas, A., Rochester, L., Ffytche, D., Howard, R., Zetterberg, H., MacKay, C., and Lovestone, S.,
“PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.”,
J Alzheimers Dis, vol. 60, no. 1, pp. 283-293, 2017.
I. Koychev, Gunn, R. N., Firouzian, A., Lawson, J., Zamboni, G., Ridha, B., Sahakian, B. J., Rowe, J. B., Thomas, A., Rochester, L., Ffytche, D., Howard, R., Zetterberg, H., MacKay, C., and Lovestone, S.,
“PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.”,
J Alzheimers Dis, vol. 60, no. 1, pp. 283-293, 2017.
W. Tajeddinn, Persson, T., Calvo-Garrido, J., Ahmed, M. Seed, Maioli, S., Vijayaraghavan, S., Kazokoglu, M. Selim, Parrado-Fernández, C., Yoshitake, T., Kehr, J., Francis, P., Winblad, B., Höglund, K., Cedazo-Minguez, A., and Aarsland, D.,
“Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.”,
J Alzheimers Dis, vol. 53, no. 1, pp. 349-61, 2016.
M. Ettcheto, Busquets, O., Cano, A., Sánchez-López, E., Manzine, P. R., Espinosa-Jimenez, T., Verdaguer, E., Sureda, F. X., Olloquequi, J., Castro-Torres, R. D., Auladell, C., Folch, J., Casadesus, G., and Camins, A.,
“Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 82, no. s1, pp. S91-S107, 2021.
R. S. Doody, Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., Siemers, E., Liu-Seifert, H., and Mohs, R.,
“Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.”,
N Engl J Med, vol. 370, no. 4, pp. 311-21, 2014.
R. Remington, Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y., Smyers, K., Page, R., Morrell, C., and Shea, T. B.,
“A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.”,
J Alzheimers Dis, 2015.
A. M. Lozano, Fosdick, L., M Chakravarty, M., Leoutsakos, J. - M., Munro, C., Oh, E., Drake, K. E., Lyman, C. H., Rosenberg, P. B., Anderson, W. S., Tang-Wai, D. F., Pendergrass, J. Cara, Salloway, S., Asaad, W. F., Ponce, F. A., Burke, A., Sabbagh, M., Wolk, D. A., Baltuch, G., Okun, M. S., Foote, K. D., McAndrews, M. Pat, Giacobbe, P., Targum, S. D., Lyketsos, C. G., and Smith, G. S.,
“A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.”,
J Alzheimers Dis, vol. 54, no. 2, pp. 777-87, 2016.
A. M. Lozano, Fosdick, L., M Chakravarty, M., Leoutsakos, J. - M., Munro, C., Oh, E., Drake, K. E., Lyman, C. H., Rosenberg, P. B., Anderson, W. S., Tang-Wai, D. F., Pendergrass, J. Cara, Salloway, S., Asaad, W. F., Ponce, F. A., Burke, A., Sabbagh, M., Wolk, D. A., Baltuch, G., Okun, M. S., Foote, K. D., McAndrews, M. Pat, Giacobbe, P., Targum, S. D., Lyketsos, C. G., and Smith, G. S.,
“A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.”,
J Alzheimers Dis, vol. 54, no. 2, pp. 777-87, 2016.
R. Olmos-Villaseñor, Sepulveda-Silva, C., Julio-Ramos, T., Fuentes-Lopez, E., Toloza-Ramirez, D., Santibañez, R. A., Copland, D. A., and Mendez-Orellana, C.,
“Phonological and Semantic Fluency in Alzheimer's Disease: A Systematic Review and Meta-Analysis.”,
J Alzheimers Dis, vol. 95, no. 1, pp. 1-12, 2023.
J. Krell-Roesch, Syrjanen, J. A., Bezold, J., Trautwein, S., Barisch-Fritz, B., Boes, K., Woll, A., Forzani, E., Kremers, W. K., Machulda, M. M., Mielke, M. M., Knopman, D. S., Petersen, R. C., Vassilaki, M., and Geda, Y. E.,
“Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging.”,
J Alzheimers Dis, vol. 79, no. 1, pp. 377-388, 2021.
G. Ben-Sadoun, Sacco, G., Manera, V., Bourgeois, J., König, A., Foulon, P., Fosty, B., Bremond, F., d'Arripe-Longueville, F., and Robert, P.,
“Physical and Cognitive Stimulation Using an Exergame in Subjects with Normal Aging, Mild and Moderate Cognitive Impairment.”,
J Alzheimers Dis, vol. 53, no. 4, pp. 1299-314, 2016.
G. Ben-Sadoun, Sacco, G., Manera, V., Bourgeois, J., König, A., Foulon, P., Fosty, B., Bremond, F., d'Arripe-Longueville, F., and Robert, P.,
“Physical and Cognitive Stimulation Using an Exergame in Subjects with Normal Aging, Mild and Moderate Cognitive Impairment.”,
J Alzheimers Dis, vol. 53, no. 4, pp. 1299-314, 2016.
B. Fenesi, Fang, H., Kovacevic, A., Oremus, M., Raina, P., and Heisz, J. J.,
“Physical Exercise Moderates the Relationship of Apolipoprotein E (APOE) Genotype and Dementia Risk: A Population-Based Study.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 297-303, 2017.
B. Fenesi, Fang, H., Kovacevic, A., Oremus, M., Raina, P., and Heisz, J. J.,
“Physical Exercise Moderates the Relationship of Apolipoprotein E (APOE) Genotype and Dementia Risk: A Population-Based Study.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 297-303, 2017.
R. Mercorio, Pergoli, L., Galimberti, D., Favero, C., Carugno, M., Valle, E. Dalla, Barretta, F., Cortini, F., Scarpini, E., Valentina, V. Bollati, and Pesatori, A. Cecilia,
“PICALM Gene Methylation in Blood of Alzheimer's Disease Patients Is Associated with Cognitive Decline.”,
J Alzheimers Dis, vol. 65, no. 1, pp. 283-292, 2018.
E. R. McGrath, Himali, J. J., Levy, D., Yang, Q., DeCarli, C. S., Courchesne, P., Satizabal, C. L., Finney, R., Vasan, R. S., Beiser, A. S., and Seshadri, S.,
“Plasma EFEMP1 Is Associated with Brain Aging and Dementia: The Framingham Heart Study.”,
J Alzheimers Dis, vol. 85, no. 4, pp. 1657-1666, 2021.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L.,
“Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.”,
J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L.,
“Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.”,
J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
] Year 